Low-grade concern — timing, disclosure, or lab context
Low-grade documented concern. Timing, disclosure, or a lab context decides whether it matters for you.
Mechanism and evidence
Same antiplatelet mechanism as with anticoagulants, graded lower because the reviewed evidence did not show significant outcome changes.
Evidence tier: label-mechanistic
The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.
What to discuss with your prescriber
- Mention it to your prescriber, especially before procedures.
- Keep the dose consistent.
← All reviewed pairs for Antiplatelets (aspirin, clopidogrel)